Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Disease, Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01403259
What this trial is testing

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 16
Testing effectiveness (Phase 2)Ended earlyNCT00003223
What this trial is testing

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 5
Testing effectiveness (Phase 2)Ended earlyNCT01405846
What this trial is testing

Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

Who this might be right for
Lung CancerHead and Neck Cancer
Papworth Hospital NHS Foundation Trust 32
Testing effectiveness (Phase 2)Looking for participantsNCT07339488
What this trial is testing

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Borderline Resectable CarcinomaUnresectable CancerEsophageal Squamous Cell Carcinoma (ESCC)+4 more
Chuangzhen Chen 43
Not applicableEnded earlyNCT03403361
What this trial is testing

Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy

Who this might be right for
Lung CancerBrain CancerHead and Neck Cancer
Washington University School of Medicine 36
Testing effectiveness (Phase 2)UnknownNCT04984018
What this trial is testing

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 73
Not applicableStudy completedNCT03057288
What this trial is testing

Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer

Who this might be right for
Esophageal NeoplasmRectal Neoplasms
Société Française d'Endoscopie Digestive 40
Testing effectiveness (Phase 2)Study completedNCT05807542
What this trial is testing

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

Who this might be right for
Esophagus Cancer
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04992988
What this trial is testing

Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaToripalimabRecurrent Nasopharyngeal Squamous Cell Carcinoma
Cancer Hospital of Guangxi Medical University 40
Not applicableStudy completedNCT00970359
What this trial is testing

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 24
Not applicableStudy completedNCT03529669
What this trial is testing

Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer

Who this might be right for
Oesophageal Cancer
University of Oxford 41
Not applicableUnknownNCT03657654
What this trial is testing

Voice Outcomes Following Thyroidectomy

Who this might be right for
Thyroid CancerThyroid Nodule
University of Virginia 45
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)UnknownNCT01872962
What this trial is testing

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 480
Not applicableStudy completedNCT04189003
What this trial is testing

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

Who this might be right for
Oropharyngeal CancerHuman Papillomavirus-Related Carcinoma
Assistance Publique - Hôpitaux de Paris 66
Not applicableLooking for participantsNCT07054086
What this trial is testing

Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Study completedNCT04543617
What this trial is testing

Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hoffmann-La Roche 760
Not applicableUnknownNCT01958697
What this trial is testing

Age and Gender Corrected Body Mass Index

Who this might be right for
Esophageal Cancer
University Hospital, Gasthuisberg 650
Not applicableStudy completedNCT07185542
What this trial is testing

Function-Preserving Surgery for Parotid Tumors: Intracapsular Versus Superficial Parotidectomy; A Randomized Clinical Trial.

Who this might be right for
Parotid TumorsParotidectomy
Al-Azhar University 120
Testing effectiveness (Phase 2)Temporarily pausedNCT05198479
What this trial is testing

Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in

Who this might be right for
Metastatic Nasopharyngeal Cancer
National Cancer Centre, Singapore 25
Next Page